Ivan S. Pires

978 total citations · 2 hit papers
32 papers, 591 citations indexed

About

Ivan S. Pires is a scholar working on Cell Biology, Molecular Biology and Physiology. According to data from OpenAlex, Ivan S. Pires has authored 32 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cell Biology, 12 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Ivan S. Pires's work include Hemoglobin structure and function (16 papers), Erythrocyte Function and Pathophysiology (8 papers) and Neonatal Health and Biochemistry (8 papers). Ivan S. Pires is often cited by papers focused on Hemoglobin structure and function (16 papers), Erythrocyte Function and Pathophysiology (8 papers) and Neonatal Health and Biochemistry (8 papers). Ivan S. Pires collaborates with scholars based in United States and Germany. Ivan S. Pires's co-authors include Darrell J. Irvine, Andre F. Palmer, Paula T. Hammond, Donald A. Belcher, Rebecca J. Carlson, Bingxu Liu, Matteo Gentili, Nir Hacohen, Paul C. Blainey and Marc A. Schwartz and has published in prestigious journals such as Science, Cell and Advanced Materials.

In The Last Decade

Ivan S. Pires

29 papers receiving 586 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

2023 128 citations Leyuan Ma, Duncan M. Morgan et al. Cell profile →
Human STING is a proton channel

2023 111 citations Ivan S. Pires, Darrell J. Irvine et al. profile →

Peers

Countries citing papers authored by Ivan S. Pires

Since Specialization

Citations

This map shows the geographic impact of Ivan S. Pires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan S. Pires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan S. Pires more than expected).

Fields of papers citing papers by Ivan S. Pires

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan S. Pires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan S. Pires. The network helps show where Ivan S. Pires may publish in the future.

Co-authorship network of co-authors of Ivan S. Pires

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan S. Pires. A scholar is included among the top collaborators of Ivan S. Pires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan S. Pires. Ivan S. Pires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High‐Throughput Microfluidic‐Mediated Assembly of Layer‐By‐Layer Nanoparticles 2025 ·Advanced Functional Materials ·Ivan S. Pires, (unknown), Heikyung Suh, Darrell J. Irvine, Paula T. Hammond	2
2	IL-12-releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer 2025 ·Nature Materials ·Ivan S. Pires, Gil Covarrubias, (unknown), Coralie M. Backlund, (unknown), Margaret M. Billingsley, (unknown), Apoorv Shanker, (unknown), (unknown), (unknown), Mariane B. Melo, Heikyung Suh, Darrell J. Irvine, Paula T. Hammond	0
3	Resuscitation from Hemorrhagic Shock with a Novel Protein Cocktail Restores Microvascular Perfusion and Protects Vital Organs 2025 ·Shock ·Carlos Muñoz, (unknown), Ivan S. Pires, Thekla Cordes, Cynthia R. Muller, (unknown), (unknown), Christian M. Metallo, Andre F. Palmer, Pedro Cabrales	1
4	Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP) 2025 ·Journal of Pharmaceutical Sciences ·(unknown), Ivan S. Pires, Mariane B. Melo, Dong Soo Yun, Andreas Wagner, (unknown), (unknown), Dietmar Katinger, (unknown), Angela Lombardo, Darrell J. Irvine	0
5	Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates 2025 ·Molecular Therapy ·Maureen Buckley, Mariluz Araínga, Laura Maiorino, Ivan S. Pires, Beomjoon Kim, (unknown), (unknown), (unknown), (unknown), (unknown), Jon M. Steichen, William R. Schief, François Villinger, Darrell J. Irvine	12
6	Surfactant-Mediated Assembly of Precision-Size Liposomes 2024 ·Chemistry of Materials ·Ivan S. Pires, (unknown), (unknown), Dong Soo Yun, Paula T. Hammond, Darrell J. Irvine	6
7	Charge‐Stabilized Nanodiscs as a New Class of Lipid Nanoparticles 2024 ·Advanced Materials ·Ivan S. Pires, (unknown), Gil Covarrubias, (unknown), (unknown), B.J. Kim, (unknown), (unknown), Darrell J. Irvine, Paula T. Hammond	3
8	Toxic side-effects of diaspirin cross-linked human hemoglobin are attenuated by the apohemoglobin-haptoglobin complex 2024 ·Biomedicine & Pharmacotherapy ·Carlos Muñoz, (unknown), (unknown), (unknown), (unknown), Ivan S. Pires, Andre F. Palmer, Pedro Cabrales	1
9	Mitigating hemoglobin‐induced nephropathy: ApoHb‐hp protection of podocytes 2024 ·Physiological Reports ·(unknown), Carlos Muñoz, (unknown), Ivan S. Pires, Andre F. Palmer, Pedro Cabrales	2
10	Coadministration of PEGylated apohemoglobin and haptoglobin can limit vascular dysfunction in the microcirculation and prevent acute inflammation 2024 ·Journal of Applied Physiology ·Carlos Muñoz, (unknown), Cynthia R. Muller, (unknown), (unknown), Ivan S. Pires, Andre F. Palmer, Pedro Cabrales	1
11	STING Protein‐Based In Situ Vaccine Synergizes CD4⁺ T, CD8⁺ T, and NK Cells for Tumor Eradication 2023 ·Advanced Healthcare Materials ·Yanpu He, Celestine Hong, (unknown), (unknown), Gil Covarrubias, Ivan S. Pires, (unknown), Paula T. Hammond, Angela M. Belcher	10
12	Controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes 2023 ·Chemical Engineering Journal ·Ivan S. Pires, Kaiyuan Ni, Mariane B. Melo, Na Li, Elana Ben‐Akiva, Laura Maiorino, (unknown), Kristen A. Rodrigues, Dong Soo Yun, B.J. Kim, (unknown), Paula T. Hammond, Darrell J. Irvine	9
13	Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity breakdown → 2023 ·Cell ·Leyuan Ma, (unknown), Duncan M. Morgan, Laura Maiorino, (unknown), Charles A. Whittaker, (unknown), Ivan S. Pires, Parisa Yousefpour, Justin M. Gregory, (unknown), (unknown), Wuhbet Abraham, Heikyung Suh, Na Li, J. Christopher Love, Darrell J. Irvine	128
14	Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors 2022 ·Bioengineering & Translational Medicine ·(unknown), Sean G. Smith, Ivan S. Pires, Sonia Iyer, Ferenc Reinhardt, Mariane B. Melo, Heikyung Suh, Robert A. Weinberg, Darrell J. Irvine, Paula T. Hammond	25
15	Synergistic combination therapy delivered via layer‐by‐layer nanoparticles induces solid tumor regression of ovarian cancer 2022 ·Bioengineering & Translational Medicine ·(unknown), Pearl Moharil, (unknown), Natalie Boehnke, Richard Panayiotou, (unknown), Gil Covarrubias, Ivan S. Pires, Ioannis K. Zervantonakis, Joan S. Brugge, Paula T. Hammond	11
16	Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme 2022 ·Biomedicine & Pharmacotherapy ·Carlos Muñoz, Ivan S. Pires, (unknown), (unknown), Andre F. Palmer, Pedro Cabrales	5
17	Enhanced Photodynamic Therapy Using the Apohemoglobin-Haptoglobin Complex as a Carrier of Aluminum Phthalocyanine 2020 ·ACS Applied Bio Materials ·Ivan S. Pires, (unknown), Carlos Muñoz, (unknown), Pedro Cabrales, Andre F. Palmer	6
18	Tangential flow filtration of haptoglobin 2020 ·Biotechnology Progress ·Ivan S. Pires, Andre F. Palmer	14
19	Anti‐inflammatory effects of haptoglobin on LPS‐stimulated macrophages: Role of HMGB1 signaling and implications in chronic wound healing 2020 ·Wound Repair and Regeneration ·(unknown), (unknown), Suneel Kumar, (unknown), (unknown), Kishan Patel, Ivan S. Pires, Martin L. Yarmush, Rene Schloss, Andre F. Palmer, François Berthiaume	21
20	Apohemoglobin-haptoglobin complex attenuates the pathobiology of circulating acellular hemoglobin and heme 2020 ·American Journal of Physiology-Heart and Circulatory Physiology ·Carlos Muñoz, Ivan S. Pires, Jin Hyen Baek, Paul W. Buehler, Andre F. Palmer, Pedro Cabrales	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact